Pictet Asset Management Sa Axsome Therapeutics, Inc. Transaction History
Pictet Asset Management Sa
- $83.4 Billion
- Q2 2023
A detailed history of Pictet Asset Management Sa transactions in Axsome Therapeutics, Inc. stock. As of the latest transaction made, Pictet Asset Management Sa holds 463,842 shares of AXSM stock, worth $55.6 Million. This represents 0.04% of its overall portfolio holdings.
Number of Shares
463,842
Previous 3,308
13921.83%
Holding current value
$55.6 Million
Previous $204,000
16238.73%
% of portfolio
0.04%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding AXSM
# of Institutions
403Shares Held
37.3MCall Options Held
507KPut Options Held
540K-
Vanguard Group Inc Valley Forge, PA3.95MShares$473 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.3MShares$396 Million0.01% of portfolio
-
Bvf Inc San Francisco, CA1.69MShares$203 Million6.93% of portfolio
-
Rtw Investments, LP New York, NY1.52MShares$182 Million2.43% of portfolio
-
Macquarie Group LTD Australia, C31.14MShares$136 Million0.15% of portfolio
About Axsome Therapeutics, Inc.
- Ticker AXSM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 42,878,000
- Market Cap $5.14B
- Description
- Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...